Connect with us


In Mice: The Experimental Anti-Obesity Drug Lowers Intestinal Inflammation



In Mice The Experimental Anti-Obesity Drug Lowers Intestinal Inflammation

An experiment has been conducted by the University of California in Association with Evans College and research assistants from Salk. This research can predict that an anti-obesity drug can be used to prevent the chances of inflammation in the intestine of the mice.

This completely shows the possibility that the same drug can be used in humans to cure patients who are suffering from inflammatory bowel diseases.

It is one of the unique approaches which is being followed over some time. This particular drug comprises the Farnesoid X receptor protein. 

It is a protein that is present in the liver and the intestine. This particular kind of protein is produced by the body when the bile juice is produced by the liver. It is known for triggering the different types of metabolic activities in the body with the help of which digestion and sugar can be easily regulated.

This particular protein can be useful for preventing every kind of possible inflammation arising in the gut area.

The most important objective behind the development of the drug was to initiate the process of metabolic reactions even in the absence of eating food. If this trial is successful, it will become the most important way to lose fat. 

Details Regarding The Drug

The name of the drug is Fexaramine. It has been useful for reducing the weight of the mice for the time being. Besides weight reduction, it also helps reduce the chances of inflammation.

In Mice: The Experimental Anti-Obesity Drug Lowers Intestinal Inflammation

This inflammation usually occurs during the process of feeding by the acidic reaction. This inflammation of the intestine can injure the human body because it produces different toxins that increase the impurities of blood and hence subject a person to a different risk. 

With the help of this medicine, the chances of inflammation will be reduced because it will try to neutralize the effect of gastric juices and acids on the inner lining of the stomach and other organs involved in digestion, such as the large intestine.

It keeps the same under control so that the balance is maintained inside the digestive system and no other complications arise. 

Until now the experimentation has only been conducted on mice. All the researchers and scientists are coming to get to develop the infrastructure with the help of which such a test could be conducted.

This report has also been published in different journals so that a sufficient amount of addition to the existing literature could take place. This is one of the most essential aspects of the research that must be taken into consideration at every cost. 

The Upcoming Course Of Action

Until now only the effect of the drug on controlling inflammation has been calculated but now an attempt would be made to certain the quantum of such effect so that the dosage could be increased or decreased depending on the results. 

The measurement of the quantity is essential to incorporate changes in the formulation of the drug so that it becomes more effective without producing any kind of side effects.

This particular drug is also being checked by the United States of America food and drug administration so that the mass scale production could take place. It will have to pass through multiple tests and approvals before the final nod is provided for consumption by human beings. 


It can be concluded that this is one of the most important aspects that takes into account the entire research. All the focus is currently on the efficacy of the drug when it is consumed by the human being. This will develop the extent of development. 

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *